Accumulation of autophagosomes confers cytotoxicity

J Biol Chem. 2017 Aug 18;292(33):13599-13614. doi: 10.1074/jbc.M117.782276. Epub 2017 Jul 3.

Abstract

Autophagy comprises the processes of autophagosome synthesis and lysosomal degradation. In certain stress conditions, increased autophagosome synthesis may be associated with decreased lysosomal activity, which may result in reduced processing of the excessive autophagosomes by the rate-limiting lysosomal activity. Thus, the excessive autophagosomes in such situations may be largely unfused to lysosomes, and their formation/accumulation under these conditions is assumed to be futile for autophagy. The role of cytotoxicity in accumulating autophagosomes (representing synthesis of autophagosomes subsequently unfused to lysosomes) has not been investigated previously. Here, we found that accumulation of autophagosomes compromised cell viability, and this effect was alleviated by depletion of autophagosome machinery proteins. We tested whether reduction in autophagosome synthesis could affect cell viability in cell models expressing mutant huntingtin and α-synuclein, given that both of these proteins cause increased autophagosome biogenesis and compromised lysosomal activity. Importantly, partial depletion of autophagosome machinery proteins Atg16L1 and Beclin 1 significantly ameliorated cell death in these conditions. Our data suggest that production/accumulation of autophagosomes subsequently unfused to lysosomes (or accumulation of autophagosomes) directly induces cellular toxicity, and this process may be implicated in the pathogenesis of neurodegenerative diseases. Therefore, lowering the accumulation of autophagosomes may represent a therapeutic strategy for tackling such diseases.

Keywords: autophagy; cell death; lysosome; mTOR complex (mTORC); neurodegenerative disease.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Autophagosomes / metabolism*
  • Autophagosomes / pathology
  • Autophagosomes / ultrastructure
  • Cell Line, Tumor
  • Cell Survival
  • Cells, Cultured
  • Embryo, Mammalian / cytology
  • Green Fluorescent Proteins / genetics
  • Green Fluorescent Proteins / metabolism
  • HEK293 Cells
  • Humans
  • Lysosomal Membrane Proteins / genetics
  • Lysosomal Membrane Proteins / metabolism
  • Lysosomal-Associated Membrane Protein 2 / genetics
  • Lysosomal-Associated Membrane Protein 2 / metabolism
  • Lysosomes / metabolism*
  • Lysosomes / pathology
  • Lysosomes / ultrastructure
  • Mice
  • Mice, Knockout
  • Microscopy, Electron, Transmission
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neurons / metabolism*
  • Neurons / pathology
  • Neurons / ultrastructure
  • Qa-SNARE Proteins / antagonists & inhibitors
  • Qa-SNARE Proteins / genetics
  • Qa-SNARE Proteins / metabolism*
  • RNA Interference
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / metabolism
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / metabolism*
  • Tumor Cells, Cultured
  • Vesicular Transport Proteins / antagonists & inhibitors
  • Vesicular Transport Proteins / genetics
  • Vesicular Transport Proteins / metabolism*

Substances

  • Lamp1 protein, mouse
  • Lysosomal-Associated Membrane Protein 2
  • Lysosomal Membrane Proteins
  • Nerve Tissue Proteins
  • Qa-SNARE Proteins
  • Recombinant Fusion Proteins
  • STX17 protein, human
  • VPS33A protein, human
  • Vesicular Transport Proteins
  • Green Fluorescent Proteins
  • MTOR protein, human
  • TOR Serine-Threonine Kinases